September 28th 2023

By Ailsa Colquhoun

ADHD meds supply alert

Supply issues until Dec

NHS England/DHSC has issued a safety alert concerning supply disruptions affecting various medications licensed for the treatment of attention deficit hyperactivity disorder (ADHD)

The affected medicines are: methylphenidate (Equasym XL) capsules, methylphenidate (Xaggitin XL, Concerta XL, Xenidate XL) prolonged-release tablets, lisdexamfetamine (Elvanse) capsules, and guanfacine (Intuniv) prolonged-release tablets.

Disruptions may last until December 2023.

Prescribers are asked to:

• not initiate new patients on products affected by this shortage until the supply issues resolve
• identify all patients currently prescribed these products
• make early contact with patients to establish how much supply they have remaining.

Where patients have insufficient supplies to last until the re-supply date, healthcare professionals should contact other dispensaries and/or patient’s specialist team for advice on alternative management options.

View the alert